JP Morgan Private Wealth Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-738
Closed -$31K 1312
2017
Q4
$31K Hold
738
﹤0.01% 1277
2017
Q3
$31K Hold
738
﹤0.01% 1227
2017
Q2
$27K Sell
738
-375
-34% -$16.6K ﹤0.01% 1220
2017
Q1
$59K Sell
1,113
-1
-0.1% -$52 ﹤0.01% 1306
2016
Q4
$59K Buy
1,114
+2
+0.2% +$114 ﹤0.01% 1218
2016
Q3
$68K Sell
1,112
-105
-9% -$6.54K ﹤0.01% 1200
2016
Q2
$81K Buy
1,217
+218
+22% +$13.8K ﹤0.01% 1216
2016
Q1
$56K Sell
999
-155
-13% -$17.4K ﹤0.01% 1183
2015
Q4
$271K Sell
1,154
-367
-24% -$80K ﹤0.01% 910
2015
Q3
$240K Buy
1,521
+460
+43% +$130K ﹤0.01% 864
2015
Q2
$401K Buy
+1,061
New +$421K ﹤0.01% 754

Other funds holding CLDX